Clinical trial Recruiting at 1 site Observational Ages 18 and up

Shortness of breath in autoimmune myasthenia gravis: causes and testing

Official title: Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"

Run by Institut de Myologie, France · NCT06866652 · Data updated 2026-11-12

We will see if patient-reported symptoms and specific clinical tests can identify the causes of shortness of breath in adults with autoimmune myasthenia gravis.

More Myasthenia Gravis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorInstitut de Myologie, France
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedApril 8, 2026
Main results expectedJune 2028
Study endsJune 2028
Registry record updatedMay 8, 2026
Trial IDNCT06866652 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with a confirmed diagnosis of autoimmune myasthenia gravis who report daily-life shortness of breath (eligible MG-ADL respiration item score) and can provide informed consent are appropriate candidates.

Probably not a fit

Patients without current dyspnea, those with other known respiratory disorders, recent respiratory infection, current MG crisis, pregnancy, or severe cognitive impairment/guardianship are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

MYaResp is a prospective observational, cross-sectional study that examines breathlessness in adults with autoimmune myasthenia gravis. Adults who report daily-life shortness of breath will complete questionnaires and undergo clinical and physiological testing to characterize the sensation, its severity, and its functional impact. The study will compare patient-reported dyspnea with disease severity measures and objective tests to identify contributing factors and the most informative diagnostic tests. Results are intended to inform targeted management strategies and monitoring to reduce respiratory deterioration and improve quality of life.

Why it matters

Potential benefit: If successful, this work could help clinicians pinpoint causes of breathlessness in MG and guide treatments to reduce discomfort and lower the risk of respiratory worsening.

How similar studies have gone: Some prior observational studies have described respiratory involvement in MG, but few have systematically linked patient-reported dyspnea with a broad set of clinical and physiological tests, so this approach is partly novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18
* Confirmed diagnosis of autoimmune MG
* Shortness of breath in daily life: score 1 or 2 on the respiration item on the MG- activities of daily living score
* Signed consent form
* Affiliated to or beneficiary of a social security scheme

Exclusion Criteria:

* Known Pregnancy
* Known respiratory disorder (other than MG)
* Recent (within past 4 weeks) respiratory infection
* Current MG crisis or exacerbation (necessitating increase in MG medication \&/or hospital admission)
* No dyspnea - score 0 or 3 on the respiration item on the MG- activities of daily living score
* Severe cognitive impairment/guardianship

Where it's running

  • Institute of Myology
    Paris, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.